Products
products details
Home > Products >
GLP-1 (1-37) (human) Peptides Diabetes CAS 87805-34-3 Catalog No. KS032002
CATALOGUE PRODUCT

Proteins

Histones

Membrane Proteins

Recombinant Proteins Expression Services

Ubiquitins

Ubiquitin

Ubiquitin Probes

Custom Peptide Services

Antigenic Peptides

Peptide Conjugations

Modified Peptides

Cyclic Peptides

Impurity Profiling

Catalog Peptides

Peptide Toxins

Peptide APIs

Peptides For Scientific Research

Diabetes Peptides

Alzheimer's Peptide

Multiple Sclerosis Peptides

Antimicrobial Peptides

Gastrointestinal Peptides

Hormone Peptide

Cardiovascular Peptides

COVID-19 Peptides

Hematology Peptides

Apoptosis Peptides

Inflammation Peptides

Cancer Peptides

Kinases Phosphatases Peptides

Miscellaneous Peptides

FRET Substrates Peptides

Immunomodulation Peptides

Enzyme Inhibitor Peptides

RGD Peptides

Neuropeptide Peptides

Peptide Analysis Services

HPLC

MS,LC-MS

MALDI-TOF

H/C/2D NMR

Elemental Analysis
Name
  • Name

GLP-1 (1-37) (human) Peptides Diabetes CAS 87805-34-3 Catalog No. KS032002

Product Details:
Catalog Number:
KS032002
Product Name:
GLP-1 (1-37) (human)
Sequence:
HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG-OH (trifluoroacetate Salt)
CAS NO.:
87805-34-3
Price/1mg:
$304
Purity:
≥95%
Molecular Formula:
C186H275N51O59
Molecular Weight:
4169.6
Form:
Lyophilized
Storage:
Store At -20°C Or -80°C
High Light: 

Human glp1 peptides

,

glp1 peptides Diabetes

,

Human glp1 diabetes

Product Description

GLP-1 (1-37) (human),CAS#: 87805-34-3, Catalog Number: KS032002

 

GLP, synthesized by posttranslational processing of proglucagon in the intestine and pancreas, plays an important role in metabolic homeostasis. It is capable of converting intestinal epithelial cells into insulin-producing cells, thus serving as a new putative therapeutic compound for the treatment of diabetes mellitus.

 

 

Technical Data

M.Wt:
4169.52
Formula:
C186H275N51O59
Sequence:
HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
Solubility:
Soluble to 5 mg/ml in water
Purity:
≥95%
Storage:
Store at -20°C
CAS No:
87805-34-3
Tags: 

Human glp1 peptides,

glp1 peptides Diabetes,

Human glp1 diabetes

Products
products details
Home > Products >
GLP-1 (1-37) (human) Peptides Diabetes CAS 87805-34-3 Catalog No. KS032002
CATALOGUE PRODUCT

Proteins

Histones

Membrane Proteins

Recombinant Proteins Expression Services

Ubiquitins

Ubiquitin

Ubiquitin Probes

Custom Peptide Services

Antigenic Peptides

Peptide Conjugations

Modified Peptides

Cyclic Peptides

Impurity Profiling

Catalog Peptides

Peptide Toxins

Peptide APIs

Peptides For Scientific Research

Diabetes Peptides

Alzheimer's Peptide

Multiple Sclerosis Peptides

Antimicrobial Peptides

Gastrointestinal Peptides

Hormone Peptide

Cardiovascular Peptides

COVID-19 Peptides

Hematology Peptides

Apoptosis Peptides

Inflammation Peptides

Cancer Peptides

Kinases Phosphatases Peptides

Miscellaneous Peptides

FRET Substrates Peptides

Immunomodulation Peptides

Enzyme Inhibitor Peptides

RGD Peptides

Neuropeptide Peptides

Peptide Analysis Services

HPLC

MS,LC-MS

MALDI-TOF

H/C/2D NMR

Elemental Analysis

GLP-1 (1-37) (human) Peptides Diabetes CAS 87805-34-3 Catalog No. KS032002

Name
  • Name
Product Details:
Catalog Number:
KS032002
Product Name:
GLP-1 (1-37) (human)
Sequence:
HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG-OH (trifluoroacetate Salt)
CAS NO.:
87805-34-3
Price/1mg:
$304
Purity:
≥95%
Molecular Formula:
C186H275N51O59
Molecular Weight:
4169.6
Form:
Lyophilized
Storage:
Store At -20°C Or -80°C
Details Link:
Https://shopping.ks-vpeptide.com/sale-470412-glp-1-1-37-human-peptides-diabetes-cas-87805-34-3-catalog-no-ks032002.htm
High Light: 

Human glp1 peptides

,

glp1 peptides Diabetes

,

Human glp1 diabetes

Product Description

GLP-1 (1-37) (human),CAS#: 87805-34-3, Catalog Number: KS032002

 

GLP, synthesized by posttranslational processing of proglucagon in the intestine and pancreas, plays an important role in metabolic homeostasis. It is capable of converting intestinal epithelial cells into insulin-producing cells, thus serving as a new putative therapeutic compound for the treatment of diabetes mellitus.

 

 

Technical Data

M.Wt:
4169.52
Formula:
C186H275N51O59
Sequence:
HDEFERHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
Solubility:
Soluble to 5 mg/ml in water
Purity:
≥95%
Storage:
Store at -20°C
CAS No:
87805-34-3
Tags: 

Human glp1 peptides,

glp1 peptides Diabetes,

Human glp1 diabetes

Contact Us
Call us

Asia & Pacific: 0551-65120828

Email
sales@ks-vpeptide.com
Address

#A2, National Health Big Data Industrial Park, Hefei, China

About Us
DRUG DISCOVERY STRUCTURAL BIOLOGY PEPTIDES AND PROTEINS HISTONES RESOURCES NEWS ABOUT US
Subscribe Newsletter
Sitemap | Privacy Policy | China Good Quality Proteins Supplier. Copyright © 2023 ks-vpeptide.com . All Rights Reserved.
Contact Us

Asia & Pacific: 0551-65120828
sales@ks-vpeptide.com

#A2, National Health Big Data Industrial Park, Hefei, China

About Us
DRUG DISCOVERY STRUCTURAL BIOLOGY PEPTIDES AND PROTEINS HISTONES RESOURCES NEWS ABOUT US
Subscribe Newsletter
Sitemap | Privacy Policy | China Good Quality Proteins Supplier. Copyright © 2023 ks-vpeptide.com . All Rights Reserved.